| Jennifer Ann Walker, MD | |
|
1370 West D Street, Wake Forest University Health Sciences/wilkes Regional, North Wilkesboro, NC 28659-3506 | |
| (336) 716-2255 | |
| Not Available |
| Full Name | Jennifer Ann Walker |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 15 Years |
| Location | 1370 West D Street, North Wilkesboro, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346477841 | NPI | - | NPPES |
| 5918053 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2011-01079 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White All Saints Medical Center Fort Worth | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Century Integrated Partners, Inc | 6406151703 | 232 |
| Dfw Critical Care Llc | 7618261884 | 12 |
News Archive
A new survey released today (20th June 2019), has found that 87% of pharmacists believe the profession has been slow in its adoption of new technology when compared to other sectors.
A surge of advertising and grassroots organizing targets mothers because women usually make the health-care decisions for families and use more health care than men, Bloomberg reports.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
Cuts included in the spending bill approved by the U.S. House of Representatives this past week would harm seniors by drastically slashing initiatives that help older Americans to sustain their economic independence and health.
› Verified 8 days ago
| Entity Name | Century Integrated Partners, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447615711 PECOS PAC ID: 6406151703 Enrollment ID: O20160224002152 |
News Archive
A new survey released today (20th June 2019), has found that 87% of pharmacists believe the profession has been slow in its adoption of new technology when compared to other sectors.
A surge of advertising and grassroots organizing targets mothers because women usually make the health-care decisions for families and use more health care than men, Bloomberg reports.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
Cuts included in the spending bill approved by the U.S. House of Representatives this past week would harm seniors by drastically slashing initiatives that help older Americans to sustain their economic independence and health.
› Verified 8 days ago
| Entity Name | Dfw Critical Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184071771 PECOS PAC ID: 7618261884 Enrollment ID: O20160810002395 |
News Archive
A new survey released today (20th June 2019), has found that 87% of pharmacists believe the profession has been slow in its adoption of new technology when compared to other sectors.
A surge of advertising and grassroots organizing targets mothers because women usually make the health-care decisions for families and use more health care than men, Bloomberg reports.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
Cuts included in the spending bill approved by the U.S. House of Representatives this past week would harm seniors by drastically slashing initiatives that help older Americans to sustain their economic independence and health.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Ann Walker, MD Po Box 344, Winston Salem, NC 27102-0344 Ph: (336) 716-2255 | Jennifer Ann Walker, MD 1370 West D Street, Wake Forest University Health Sciences/wilkes Regional, North Wilkesboro, NC 28659-3506 Ph: (336) 716-2255 |
News Archive
A new survey released today (20th June 2019), has found that 87% of pharmacists believe the profession has been slow in its adoption of new technology when compared to other sectors.
A surge of advertising and grassroots organizing targets mothers because women usually make the health-care decisions for families and use more health care than men, Bloomberg reports.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
Cuts included in the spending bill approved by the U.S. House of Representatives this past week would harm seniors by drastically slashing initiatives that help older Americans to sustain their economic independence and health.
› Verified 8 days ago
Dr. Nathan Grant Davis, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Wake Forest Baptist Health- Wilkes Medical Center, 1370 W D St, North Wilkesboro, NC 28659 Phone: 336-651-8100 | |
Dr. Whitney Marie Plunkett, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1370 W D St, North Wilkesboro, NC 28659 Phone: 336-716-2255 | |
Dr. Alice Marie Horrell, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1370 W D St, North Wilkesboro, NC 28659 Phone: 336-716-2255 | |
Dennis Kimbleton, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1370 W D St, North Wilkesboro, NC 28659 Phone: 336-651-8100 Fax: 336-716-5438 | |
Mr. Wun Chi Augustin, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1370 W D St, North Wilkesboro, NC 28659 Phone: 336-716-2255 | |
John Gaillard, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1370 W D St, North Wilkesboro, NC 28659 Phone: 336-716-2255 | |
Scott Lewis Korn, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1370 West D Street, Wilkes Regional Medical Center Ed, North Wilkesboro, NC 28659 Phone: 336-651-8102 Fax: 336-651-8190 |